Effects of Interventions for Improving Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Chinese Young Adults for Prevention of Liver Cancer—A Randomized Controlled Trial

被引:0
|
作者
Yi Du
Kendra L. Ratnapradipa
Dejun Su
Jianghu Dong
Fedja A. Rochling
Paraskevi A. Farazi
机构
[1] University of Nebraska Medical Center,Department of Epidemiology, College of Public Health
[2] University of Nebraska Medical Center,Department of Health Promotion, College of Public Health
[3] University of Nebraska Medical Center,Department of Biostatistics, College of Public Health
[4] University of Nebraska Medical Center,Department of Internal Medicine, Division of Gastroenterology and Hepatology
来源
关键词
Nonalcoholic fatty liver disease; Liver cancer; Educational intervention; Awareness; Knowledge; Chinese young adults;
D O I
暂无
中图分类号
学科分类号
摘要
Chinese young adults (CYA), who are at an increasing risk of developing nonalcoholic fatty liver disease (NAFLD), which in turn increases the risk of liver cancer, are an ideal target population to deliver educational interventions to improve their awareness and knowledge of NAFLD and consequently reduce their risk of developing NAFLD. The purpose of this study was to determine the efficacy of two interventions to improve awareness and knowledge of NAFLD among CYA for the prevention of liver cancer. Between May and July 2021, 1373 undergraduate students aged 18 to 25 years in one university in China completed a web-based, self-administered survey distributed through WeChat app. One week after completion of the baseline survey, all eligible participants were randomly assigned to a pamphlet, a video intervention, or no intervention (control group), with follow-up assessments immediately and 1-month post-intervention. The 7-page pamphlet or 6.5-min video had information on NAFLD. Self-assessments included NAFLD awareness, lean NAFLD awareness, and knowledge scores of NAFLD. About 26% of participants had NAFLD awareness at baseline. Compared with controls, participants in both interventions showed significant improvement of awareness of NAFLD (pamphlet, + 46.0%; video, + 44.3%; control, + 18.7%; OR [95% CI], 3.13 [2.19–4.47] and 2.84 [1.98–4.08]), awareness of lean NAFLD (pamphlet, + 41.2%; video, + 43.0%; control, + 14.5%; OR [95% CI], 2.84 [1.62–4.99] and 2.61 [1.50–4.54]), and knowledge score of NAFLD (pamphlet, + 64.2%; video, + 68.9%; control, − 1.0%; OR [95% CI], 1.62 [1.47–1.80] and 1.67 [1.50–1.86]) at immediately post-intervention. Delivering NAFLD education through a pamphlet or video intervention was effective in improving the awareness and knowledge of NAFLD among CYA.
引用
收藏
页码:253 / 263
页数:10
相关论文
共 50 条
  • [1] Effects of Interventions for Improving Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Chinese Young Adults for Prevention of Liver Cancer-A Randomized Controlled Trial
    Du, Yi
    Ratnapradipa, Kendra L.
    Su, Dejun
    Dong, Jianghu
    Rochling, Fedja A.
    Farazi, Paraskevi A.
    JOURNAL OF CANCER EDUCATION, 2024, 39 (03) : 253 - 263
  • [2] Factors Associated with Awareness and Knowledge of Nonalcoholic Fatty Liver Disease, a Liver Cancer Etiological Factor, Among Chinese Young Adults
    Du, Yi
    Su, Dejun
    Ratnapradipa, Kendra L.
    Dong, Jianghu
    Rochling, Fedja A.
    Farazi, Paraskevi A.
    JOURNAL OF CANCER EDUCATION, 2023, 38 (04) : 1177 - 1186
  • [3] Factors Associated with Awareness and Knowledge of Nonalcoholic Fatty Liver Disease, a Liver Cancer Etiological Factor, Among Chinese Young Adults
    Yi Du
    Dejun Su
    Kendra L. Ratnapradipa
    Jianghu Dong
    Fedja A. Rochling
    Paraskevi A. Farazi
    Journal of Cancer Education, 2023, 38 : 1177 - 1186
  • [4] Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
    Weng, Meng-Tzu
    Yang, Po-Jen
    Liu, Pan-Fu
    Chang, Chin-Hao
    Lee, Hsuan-Shu
    Sheu, Jin-Chuan
    Nien, Hsiao-Ching
    HEPATOLOGY INTERNATIONAL, 2024, : 405 - 414
  • [5] Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
    Dalai, Motij Kumar
    Chandnani, Sanjay Jagdish
    HEPATOLOGY INTERNATIONAL, 2025,
  • [6] Letter: Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
    Dalai, Motij Kumar
    Chandnani, Sanjay Jagdish
    HEPATOLOGY INTERNATIONAL, 2025,
  • [7] POOR LIVER DISEASE AWARENESS AMONG ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES
    Biswas, Rakesh
    Paik, James M.
    Arshad, Tamoore
    Golabi, Pegah
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY, 2020, 72 : 403A - 403A
  • [8] EFFECTS OF TESAMORELIN ON NONALCOHOLIC FATTY LIVER DISEASE IN HIV: A RANDOMIZED TRIAL
    Stanley, Takara L.
    Fourman, Lindsay T.
    Feldpausch, Meghan N.
    Purdy, Julia
    Zheng, Isabel
    Pan, Chelsea
    Lee, Hang
    Corey, Kathleen E.
    Chung, Raymond T.
    Torriani, Martin
    Kleiner, David
    Hadigan, Colleen
    Grinspoon, Steven K.
    HEPATOLOGY, 2019, 70 : 1343A - 1344A
  • [9] Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
    Kwon, Hyemi
    Han, Kyung-Do
    Moon, Sun Joon
    Park, Se Eun
    Rhee, Eun-Jung
    Lee, Won-Young
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (03): : e1095 - e1104
  • [10] Effects of curcuminoids on inflammatory status in patients with nonalcoholic fatty liver disease: A randomized controlled trial
    Saberi-Karimian, Maryam
    Keshvari, Mahtab
    Ghayour-Mobarhan, Majid
    Salehizadeh, Leila
    Rahmani, Sepideh
    Behnam, Behzad
    Jamialahmadi, Tannaz
    Asgary, Sedigheh
    Sahebkar, Amirhossein
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49